Summary/Abstract
Myofascial Pain Syndrome (MPS) is a common overlooked and underdiagnosed condition. MPS can evolve into fibromyalgia, and many studies focus on central mechanisms. Therefore, the purpose of this scoping review is to systematically search cross-disciplinary studies of MPS, focusing on mechanical aspects, and suggest an organic mechanism explaining how it might evolve into fibromyalgia. Systematic searches on MEDLINE, EMBASE, COCHRANE, PEDro, and medrXiv were performed, following PRISMA-ScR guidelines. 798 items included. Review suggests fascia can adapt to various states by reversibly changing biomechanical and physical properties. Trigger points, tension, and pain are a hallmark of MPS. Myofibroblasts play a role in sustained fascial tension which can propagate and is a bases for a tensegrity framework. Movement and mechanical interventions treat and prevent MPS, while living sedentarily predisposes to MPS. MPS can be seen as a pathological state of imbalance in a natural process; manifesting from inherent properties of the fascia, triggered by a disrupted biomechanical interplay. MPS might evolve into fibromyalgia through deranged myofibroblasts in connective tissue, or “fascial armoring”, which may explain pain distribution, decreased pressure/pain thresholds, occasional resolution after surgery, etc. Lifestyle is linked to pain and suffering. The mechanism of needling is suggested to be mostly mechanical.
Perspective This scoping review highlights the role of myofibroblasts in myofascial pain syndrome (MPS). MPS might evolve into fibromyalgia through “fascial armoring”. A global percutaneous needle fasciotomy that respects tensegrity principles may treat MPS/fibromyalgia more effectively. Functional somatic syndromes can be seen as one entity, perhaps sharing a common rheuma-phycho-neurological mechanism.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
irrelevant to this manuscript
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Shiloh Plaut- sole researcher and author of this manuscript including conception, organization, literature review, integration of information, findings analysis, manuscript preparation and writing.
Data Availability
All data is available in the manuscript file